Coronavirus Update: How Should Remdesivir Be Priced? ICER Are In Two Minds

Plus Moderna and Daiichi Sankyo Updates

 
• By Scrip Team
  
Vials_Remdesivir
Gilead will be heartened by the 'cost recovery' model, but new dexamethasone data is likely to have the biggest impact.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip